Bristol Myers Squibb (BMYMP) Return on Capital Employed (2016 - 2025)
Bristol Myers Squibb (BMYMP) has disclosed Return on Capital Employed for 16 consecutive years, with 0.07% as the latest value for Q4 2025.
- Quarterly Return on Capital Employed rose 26.0% to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07% through Dec 2025, up 26.0% year-over-year, with the annual reading at 0.07% for FY2025, 25.0% up from the prior year.
- Return on Capital Employed for Q4 2025 was 0.07% at Bristol Myers Squibb, up from 0.1% in the prior quarter.
- The five-year high for Return on Capital Employed was 0.02% in Q1 2023, with the low at 0.32% in Q4 2024.
- Average Return on Capital Employed over 5 years is 0.11%, with a median of 0.08% recorded in 2025.
- The sharpest move saw Return on Capital Employed fell -29bps in 2024, then rose 26bps in 2025.
- Over 5 years, Return on Capital Employed stood at 0.02% in 2021, then tumbled by -54bps to 0.03% in 2022, then increased by 1bps to 0.03% in 2023, then plummeted by -915bps to 0.32% in 2024, then surged by 80bps to 0.07% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.07%, 0.1%, and 0.11% for Q4 2025, Q3 2025, and Q2 2025 respectively.